U.S. Government Agency - Mortgage Securities - 144.1% |
| | Principal Amount (a) (000s) | Value ($) (000s) |
Fannie Mae - 3.7% | | | |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 1.460% 6.085% 1/1/35 (b)(c) | | 10 | 10 |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 1.480% 5.73% 7/1/34 (b)(c) | | 4 | 4 |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 1.510% 7.316% 2/1/33 (b)(c) | | 7 | 7 |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 1.530% 5.785% 12/1/34 (b)(c) | | 8 | 8 |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 1.530% 5.785% 3/1/35 (b)(c) | | 8 | 8 |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 1.530% 5.94% 3/1/36 (b)(c) | | 35 | 36 |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 1.550% 7.119% 9/1/33 (b)(c) | | 106 | 107 |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 1.550% 7.192% 10/1/33 (b)(c) | | 4 | 4 |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 1.560% 7.359% 7/1/35 (b)(c) | | 6 | 6 |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 1.620% 5.984% 3/1/33 (b)(c) | | 26 | 26 |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 1.640% 5.779% 11/1/36 (b)(c) | | 34 | 35 |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 1.640% 5.864% 5/1/35 (b)(c) | | 67 | 68 |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 1.710% 5.857% 8/1/35 (b)(c) | | 79 | 80 |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 1.890% 5.581% 8/1/35 (b)(c) | | 41 | 41 |
U.S. TREASURY 1 YEAR INDEX + 2.180% 6.129% 7/1/36 (b)(c) | | 29 | 29 |
U.S. TREASURY 1 YEAR INDEX + 2.280% 6.404% 10/1/33 (b)(c) | | 12 | 13 |
U.S. TREASURY 1 YEAR INDEX + 2.460% 6.281% 7/1/34 (b)(c) | | 101 | 102 |
U.S. TREASURY 1 YEAR INDEX + 2.460% 6.585% 9/1/34 (b)(c) | | 22 | 22 |
1.5% 11/1/35 to 1/1/51 (d) | | 12,373 | 9,799 |
2% 2/1/28 to 7/1/36 | | 13,486 | 11,784 |
2.5% 10/1/31 to 5/1/42 | | 11,320 | 9,987 |
3% 11/1/51 to 3/1/52 | | 1,591 | 1,324 |
3.5% 10/1/41 to 4/1/52 (d) | | 18,512 | 16,120 |
5% 10/1/52 to 12/1/52 | | 4,990 | 4,784 |
5.5% 11/1/52 (e) | | 8,872 | 8,629 |
6% 11/1/52 to 6/1/53 (d) | | 10,309 | 10,316 |
6.5% 3/1/54 | | 799 | 806 |
8.5% 12/1/27 | | 6 | 6 |
TOTAL FANNIE MAE | | | 74,161 |
Freddie Mac - 2.9% | | | |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 1.860% 5.239% 4/1/36 (b)(c) | | 47 | 49 |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 1.860% 6.11% 8/1/34 (b)(c) | | 41 | 42 |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 1.880% 6.368% 10/1/36 (b)(c) | | 109 | 111 |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 1.960% 5.711% 6/1/33 (b)(c) | | 76 | 77 |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 1.990% 6% 10/1/35 (b)(c) | | 60 | 60 |
Refinitiv USD IBOR Consumer Cash Fallbacks Term 1Y + 2.030% 6.158% 3/1/33 (b)(c) | | 1 | 1 |
U.S. TREASURY 1 YEAR INDEX + 2.030% 5.463% 6/1/33 (b)(c) | | 81 | 82 |
U.S. TREASURY 1 YEAR INDEX + 2.230% 6.341% 12/1/35 (b)(c) | | 343 | 346 |
U.S. TREASURY 1 YEAR INDEX + 2.260% 5.53% 6/1/33 (b)(c) | | 138 | 139 |
U.S. TREASURY 1 YEAR INDEX + 2.430% 6.378% 3/1/35 (b)(c) | | 253 | 256 |
1.5% 11/1/35 to 2/1/51 | | 15,502 | 11,748 |
2% 3/1/36 to 12/1/36 | | 8,399 | 7,292 |
2.5% 11/1/31 to 4/1/42 | | 17,504 | 14,950 |
3% 4/1/34 to 3/1/52 | | 531 | 467 |
3.5% 3/1/42 to 3/1/52 | | 11,649 | 10,245 |
5% 11/1/52 | | 1,304 | 1,251 |
5.5% 3/1/53 (d) | | 2,193 | 2,161 |
6% 9/1/53 | | 1,620 | 1,613 |
6.5% 9/1/53 to 10/1/53 (d) | | 8,390 | 8,555 |
TOTAL FREDDIE MAC | | | 59,445 |
Ginnie Mae - 120.7% | | | |
3% 5/15/27 to 12/20/50 | | 166,763 | 145,216 |
3.5% 9/15/26 to 5/20/50 (f) | | 226,305 | 203,710 |
3.7% 10/15/42 | | 3,742 | 3,396 |
4% 5/15/44 | | 841 | 780 |
4.5% 7/15/33 to 4/20/53 | | 91,994 | 86,915 |
4.75% 7/15/40 | | 330 | 317 |
4.875% 9/15/39 to 12/15/39 | | 2,931 | 2,828 |
5.09% 4/15/36 to 11/15/36 | | 2,356 | 2,306 |
5.15% 2/15/36 | | 91 | 89 |
5.2% 7/15/36 | | 46 | 45 |
5.25% 4/15/36 to 4/15/37 | | 153 | 151 |
5.39% 5/15/36 | | 43 | 42 |
5.45% 2/15/37 | | 396 | 392 |
5.5% 10/15/32 to 2/20/42 | | 3,527 | 3,544 |
5.6% 11/15/36 | | 129 | 130 |
5.85% 1/15/37 | | 28 | 28 |
6.45% 1/15/32 to 8/15/32 | | 66 | 68 |
6.5% 10/15/25 to 1/15/39 | | 2,391 | 2,465 |
7% to 7% 5/15/24 to 9/20/34 | | 4,803 | 4,938 |
7.25% 9/15/27 | | 15 | 16 |
7.5% to 7.5% 11/15/24 to 8/20/32 | | 1,573 | 1,608 |
8% 8/15/24 to 9/15/31 | | 369 | 377 |
8.5% 9/15/30 to 2/15/31 | | 94 | 98 |
9% 10/15/24 | | 0 | 0 |
2% 9/20/50 to 2/20/52 | | 396,884 | 312,733 |
2% 5/1/54 (g) | | 25,000 | 19,678 |
2% 5/1/54 (g) | | 12,300 | 9,681 |
2% 5/1/54 (g) | | 36,800 | 28,966 |
2% 5/1/54 (g) | | 48,600 | 38,254 |
2% 5/1/54 (g) | | 18,350 | 14,443 |
2% 5/1/54 (g) | | 30,550 | 24,046 |
2% 5/1/54 (g) | | 16,900 | 13,302 |
2% 5/1/54 (g) | | 10,175 | 8,009 |
2% 6/1/54 (g) | | 23,950 | 18,865 |
2% 6/1/54 (g) | | 16,650 | 13,115 |
2% 6/1/54 (g) | | 12,100 | 9,531 |
2% 6/1/54 (g) | | 47,650 | 37,534 |
2.25% 5/20/50 | | 1,852 | 1,466 |
2.375% 5/20/50 | | 1,337 | 1,070 |
2.5% 3/15/28 to 10/20/52 | | 402,792 | 331,676 |
2.625% 5/20/50 | | 3,421 | 2,798 |
2.75% 5/20/50 | | 1,250 | 1,032 |
3% 5/1/54 (g) | | 115,350 | 98,123 |
3% 5/1/54 (g) | | 57,700 | 49,083 |
3% 5/1/54 (g) | | 49,150 | 41,810 |
3% 5/1/54 (g) | | 20,100 | 17,098 |
3.25% 2/20/41 to 7/20/46 | | 846 | 708 |
3.375% 5/20/50 | | 444 | 385 |
3.74% 7/20/42 to 8/20/42 | | 314 | 284 |
3.75% 10/20/41 to 7/20/47 | | 15,286 | 13,825 |
4% 2/20/33 to 1/20/50 | | 129,586 | 120,537 |
4.25% 1/20/46 | | 289 | 269 |
4.5% 5/1/54 (g) | | 5,750 | 5,357 |
4.5% 5/1/54 (g) | | 3,950 | 3,680 |
4.5% 5/1/54 (g) | | 40,000 | 37,264 |
5% 6/20/29 to 7/20/48 | | 37,817 | 37,088 |
5% 5/1/54 (g) | | 27,600 | 26,425 |
5% 5/1/54 (g) | | 53,200 | 50,935 |
5.35% 4/20/29 to 12/20/30 | | 2,931 | 2,905 |
5.5% 5/1/54 (g) | | 20,900 | 20,500 |
5.5% 5/1/54 (g) | | 10,100 | 9,907 |
5.5% 6/1/54 (g) | | 11,500 | 11,259 |
5.75% 9/20/39 to 9/20/40 | | 5,528 | 5,608 |
6% to 6% 12/20/27 to 3/15/39 | | 4,717 | 4,791 |
6% 5/1/54 (g) | | 59,650 | 59,839 |
6% 5/1/54 (g) | | 45,150 | 45,293 |
6% 5/1/54 (g) | | 40,000 | 40,127 |
6% 6/1/54 (g) | | 33,250 | 33,183 |
6% 6/1/54 (g) | | 33,225 | 33,158 |
6% 6/1/54 (g) | | 38,325 | 38,247 |
6% 7/1/54 (g) | | 33,250 | 33,100 |
6% 7/1/54 (g) | | 26,975 | 26,853 |
6% 7/1/54 (g) | | 40,000 | 39,819 |
6% 7/1/54 (g) | | 21,575 | 21,477 |
6.5% 5/1/54 (g) | | 65,000 | 65,822 |
6.5% 5/1/54 (g) | | 53,950 | 54,632 |
6.5% 5/1/54 (g) | | 55,800 | 56,506 |
7.395% 7/20/25 to 2/20/27 | | 62 | 62 |
TOTAL GINNIE MAE | | | 2,451,617 |
Uniform Mortgage Backed Securities - 16.8% | | | |
2% 5/1/54 (g) | | 3,700 | 2,794 |
2% 5/1/54 (g) | | 10,550 | 7,968 |
2% 5/1/54 (g) | | 3,100 | 2,341 |
2% 5/1/54 (g) | | 300 | 227 |
2% 5/1/54 (g) | | 2,200 | 1,662 |
2% 5/1/54 (g) | | 4,400 | 3,323 |
2% 5/1/54 (g) | | 3,900 | 2,945 |
2% 6/1/54 (g) | | 475 | 359 |
2% 6/1/54 (g) | | 950 | 718 |
2% 6/1/54 (g) | | 400 | 302 |
2% 6/1/54 (g) | | 200 | 151 |
2% 6/1/54 (g) | | 500 | 378 |
2% 6/1/54 (g) | | 1,950 | 1,474 |
2% 6/1/54 (g) | | 2,950 | 2,230 |
2.5% 5/1/54 (g) | | 3,300 | 2,612 |
2.5% 5/1/54 (g) | | 5,000 | 3,958 |
2.5% 5/1/54 (g) | | 200 | 158 |
2.5% 6/1/54 (g) | | 50 | 40 |
2.5% 6/1/54 (g) | | 100 | 79 |
2.5% 6/1/54 (g) | | 50 | 40 |
3.5% 5/1/54 (g) | | 10,600 | 9,138 |
4% 5/1/54 (g) | | 16,000 | 14,302 |
4% 6/1/54 (g) | | 8,000 | 7,153 |
4.5% 5/1/54 (g) | | 5,750 | 5,300 |
4.5% 5/1/54 (g) | | 3,950 | 3,641 |
5% 5/1/54 (g) | | 53,200 | 50,438 |
6% 5/1/54 (g) | | 10,000 | 9,913 |
6% 5/1/54 (g) | | 4,600 | 4,560 |
6% 5/1/54 (g) | | 3,300 | 3,271 |
6% 5/1/54 (g) | | 6,350 | 6,295 |
6% 5/1/54 (g) | | 6,350 | 6,295 |
6% 5/1/54 (g) | | 9,600 | 9,516 |
6% 5/1/54 (g) | | 5,600 | 5,551 |
6% 5/1/54 (g) | | 8,700 | 8,624 |
6% 5/1/54 (g) | | 3,700 | 3,668 |
6% 5/1/54 (g) | | 18,000 | 17,843 |
6% 6/1/54 (g) | | 9,825 | 9,736 |
6% 6/1/54 (g) | | 9,850 | 9,761 |
6.5% 5/1/54 (g) | | 11,750 | 11,844 |
6.5% 5/1/54 (g) | | 8,050 | 8,114 |
6.5% 5/1/54 (g) | | 101,700 | 102,514 |
TOTAL UNIFORM MORTGAGE BACKED SECURITIES | | | 341,236 |
TOTAL U.S. GOVERNMENT AGENCY - MORTGAGE SECURITIES (Cost $3,106,060) | | | 2,926,459 |
| | | |
Collateralized Mortgage Obligations - 13.2% |
| | Principal Amount (a) (000s) | Value ($) (000s) |
U.S. Government Agency - 13.2% | | | |
Fannie Mae: | | | |
planned amortization class: | | | |
Series 2012-93 Class QW, 5% 1/25/42 | | 29 | 29 |
Series 2017-1 Class JP, 3.5% 4/25/45 | | 200 | 189 |
Series 2017-22 Class JN, 4.5% 4/25/46 | | 437 | 419 |
Series 2019-52 Class M, 3.5% 3/25/49 | | 64 | 60 |
Series 2019-64 Class MJ, 4.5% 6/25/49 | | 809 | 753 |
Series 2019-74 Class LB, 3% 10/25/49 | | 373 | 319 |
Series 2021-26 Class HC, 1% 11/25/49 | | 3,597 | 2,940 |
sequential payer: | | | |
Series 2017-89 Class KV, 3.5% 8/25/47 | | 1,001 | 974 |
Series 2020-101 Class BA, 1.5% 9/25/45 | | 1,975 | 1,645 |
Series 2020-49 Class JA, 2% 8/25/44 | | 829 | 737 |
Series 2020-67 Class KZ, 3.25% 9/25/40 | | 2,479 | 2,199 |
Series 2020-75 Class HA, 1.5% 12/25/44 | | 6,899 | 5,860 |
Series 2021-68 Class A, 2% 7/25/49 | | 1,714 | 1,302 |
Series 2021-85 Class L, 2.5% 8/25/48 | | 949 | 803 |
Series 2021-96 Class HA, 2.5% 2/25/50 | | 1,511 | 1,266 |
Series 2022-3: | | | |
Class G, 2% 11/25/47 | | 11,011 | 9,166 |
Class N, 2% 10/25/47 | | 10,324 | 8,658 |
Series 2022-4 Class B, 2.5% 5/25/49 | | 1,102 | 930 |
Series 2016-3 Class IP, 4% 2/25/46 (h) | | 14,799 | 2,715 |
Series 2016-78 Class IO, 3.5% 11/25/46 (h) | | 3,896 | 612 |
Series 2020-45 Class JL, 3% 7/25/40 | | 97 | 85 |
Series 2021-59 Class H, 2% 6/25/48 | | 970 | 757 |
Series 2021-66: | | | |
Class DA, 2% 1/25/48 | | 1,046 | 821 |
Class DM, 2% 1/25/48 | | 1,111 | 872 |
Fannie Mae Stripped Mortgage-Backed Securities: | | | |
Series 331 Class 12, 6.5% 2/25/33 (b)(h) | | 75 | 12 |
Series 339 Class 5, 5.5% 7/25/33 (h) | | 102 | 15 |
Series 343 Class 16, 5.5% 5/25/34 (h) | | 95 | 15 |
Freddie Mac: | | | |
planned amortization class: | | | |
Series 2022-5213 Class JM, 3.5% 9/25/51 | | 4,180 | 3,867 |
Series 2022-5224 Class DQ, 3.75% 8/25/44 | | 2,334 | 2,172 |
Series 2220 Class PD, 8% 3/15/30 | | 159 | 164 |
Series 40 Class K, 6.5% 8/17/24 | | 0 | 0 |
sequential payer: | | | |
Series 2020-5018: | | | |
Class LC, 3% 10/25/40 | | 656 | 575 |
Class LT, 3.25% 10/25/40 | | 2,563 | 2,291 |
Class LY, 3% 10/25/40 | | 498 | 437 |
Series 2021-5175 Class CB, 2.5% 4/25/50 | | 5,448 | 4,590 |
Series 2021-5180 Class KA, 2.5% 10/25/47 | | 1,093 | 928 |
Series 2022-5191 Class CA, 2.5% 4/25/50 | | 1,291 | 1,079 |
Series 2022-5198 Class BA, 2.5% 11/25/47 | | 3,548 | 3,068 |
Series 2204 Class N, 7.5% 12/20/29 | | 351 | 357 |
Series 2020-5041 Class LB, 3% 11/25/40 | | 1,117 | 979 |
Series 2021-5083 Class VA, 1% 8/15/38 | | 3,911 | 3,629 |
Series 2021-5176 Class AG, 2% 1/25/47 | | 4,104 | 3,444 |
Series 2021-5182 Class A, 2.5% 10/25/48 | | 7,114 | 6,020 |
Freddie Mac Multi-family Structured pass-thru certificates sequential payer Series 2021-5159 Class GC, 2% 11/25/47 | | 875 | 744 |
Ginnie Mae guaranteed REMIC pass-thru certificates: | | | |
floater: | | | |
Series 2007-37 Class TS, 6.570% - CME Term SOFR 1 Month Index 1.2562% 6/16/37 (b)(h)(i) | | 535 | 42 |
Series 2008-51 Class FE, CME Term SOFR 1 Month Index + 0.860% 6.1838% 6/16/38 (b)(c) | | 144 | 143 |
Series 2008-57 Class AF, CME Term SOFR 1 Month Index + 0.690% 6.0099% 7/20/38 (b)(c) | | 364 | 361 |
Series 2010-130 Class KF, CME Term SOFR 1 Month Index + 0.760% 6.0838% 10/16/40 (b)(c) | | 673 | 669 |
Series 2010-H03 Class FA, CME Term SOFR 1 Month Index + 0.660% 5.9967% 3/20/60 (b)(c)(j) | | 3,641 | 3,638 |
Series 2010-H17 Class FA, CME Term SOFR 1 Month Index + 0.440% 5.7767% 7/20/60 (b)(c)(j) | | 4,562 | 4,547 |
Series 2010-H18 Class AF, CME Term SOFR 1 Month Index + 0.410% 5.7371% 9/20/60 (b)(c)(j) | | 4,530 | 4,511 |
Series 2010-H19 Class FG, CME Term SOFR 1 Month Index + 0.410% 5.7371% 8/20/60 (b)(c)(j) | | 4,215 | 4,198 |
Series 2010-H27 Class FA, CME Term SOFR 1 Month Index + 0.380% 5.8171% 12/20/60 (b)(c)(j) | | 1,722 | 1,717 |
Series 2011-H05 Class FA, CME Term SOFR 1 Month Index + 0.610% 5.9371% 12/20/60 (b)(c)(j) | | 1,295 | 1,293 |
Series 2011-H07 Class FA, CME Term SOFR 1 Month Index + 0.610% 5.9371% 2/20/61 (b)(c)(j) | | 267 | 267 |
Series 2011-H12 Class FA, CME Term SOFR 1 Month Index + 0.600% 5.9271% 2/20/61 (b)(c)(j) | | 1,595 | 1,592 |
Series 2011-H13 Class FA, CME Term SOFR 1 Month Index + 0.610% 5.9371% 4/20/61 (b)(c)(j) | | 1,343 | 1,341 |
Series 2011-H14: | | | |
Class FB, CME Term SOFR 1 Month Index + 0.610% 5.9371% 5/20/61 (b)(c)(j) | | 1,575 | 1,573 |
Class FC, CME Term SOFR 1 Month Index + 0.610% 5.9371% 5/20/61 (b)(c)(j) | | 1,535 | 1,533 |
Series 2011-H17 Class FA, CME Term SOFR 1 Month Index + 0.640% 5.9671% 6/20/61 (b)(c)(j) | | 1,733 | 1,731 |
Series 2011-H21 Class FA, CME Term SOFR 1 Month Index + 0.710% 6.0371% 10/20/61 (b)(c)(j) | | 1,786 | 1,785 |
Series 2012-48 Class FA, CME Term SOFR 1 Month Index + 0.460% 5.7838% 4/16/42 (b)(c) | | 259 | 256 |
Series 2012-76 Class GF CME Term SOFR 1 Month Index + 0.410% 5.7338% 6/16/42 (b)(c) | | 294 | 289 |
Series 2012-H01 Class FA, CME Term SOFR 1 Month Index + 0.810% 6.1371% 11/20/61 (b)(c)(j) | | 2,047 | 2,049 |
Series 2012-H03 Class FA, CME Term SOFR 1 Month Index + 0.810% 6.1371% 1/20/62 (b)(c)(j) | | 1,017 | 1,018 |
Series 2012-H06 Class FA, CME Term SOFR 1 Month Index + 0.740% 6.0671% 1/20/62 (b)(c)(j) | | 1,976 | 1,977 |
Series 2012-H07 Class FA, CME Term SOFR 1 Month Index + 0.740% 6.0671% 3/20/62 (b)(c)(j) | | 1,037 | 1,037 |
Series 2012-H21 Class DF, CME Term SOFR 1 Month Index + 0.760% 6.0871% 5/20/61 (b)(c)(j) | | 23 | 23 |
Series 2015-H13 Class FL, CME Term SOFR 1 Month Index + 0.390% 5.7171% 5/20/63 (b)(c)(j) | | 26 | 25 |
Series 2015-H19 Class FA, CME Term SOFR 1 Month Index + 0.310% 5.6371% 4/20/63 (b)(c)(j) | | 39 | 38 |
Series 2016-12 Class FA, CME Term SOFR 1 Month Index + 0.460% 5.7799% 1/20/46 (b)(c) | | 710 | 682 |
Series 2019-42 Class FK, CME Term SOFR 1 Month Index + 0.560% 5.8799% 4/20/49 (b)(c) | | 4,993 | 4,940 |
planned amortization class: | | | |
Series 2003-74 Class PZ, 5.5% 8/20/33 | | 2,242 | 2,221 |
Series 2004-19 Class DP, 5.5% 3/20/34 | | 0 | 0 |
Series 2005-24 Class TC, 5.5% 3/20/35 | | 1,589 | 1,564 |
Series 2005-57 Class PB, 5.5% 7/20/35 | | 2,332 | 2,330 |
Series 2006-50 Class JC, 5% 6/20/36 | | 298 | 295 |
Series 2011-136 Class WI, 4.5% 5/20/40 (h) | | 139 | 8 |
Series 2015-24 Class PI, 3.5% 2/20/45 (h) | | 7,865 | 1,180 |
Series 2016-69 Class WA, 3% 2/20/46 | | 937 | 833 |
Series 2017-134 Class BA, 2.5% 11/20/46 | | 397 | 348 |
Series 2017-139 Class K, 3% 8/20/47 | | 13,159 | 11,695 |
Series 2017-153 Class GA, 3% 9/20/47 | | 2,582 | 2,245 |
Series 2017-182 Class KA, 3% 10/20/47 | | 2,058 | 1,810 |
Series 2018-13 Class Q, 3% 4/20/47 | | 2,523 | 2,270 |
sequential payer: | | | |
Series 2003-75 Class ZA, 5.5% 9/20/33 | | 685 | 685 |
Series 2004-24 Class ZM, 5% 4/20/34 | | 1,421 | 1,368 |
Series 2004-46 Class BZ, 6% 6/20/34 | | 868 | 859 |
Series 2004-86 Class G, 6% 10/20/34 | | 6,273 | 6,327 |
Series 2005-26 Class ZA, 5.5% 1/20/35 | | 6,533 | 6,537 |
Series 2005-47 Class ZY, 6% 6/20/35 | | 4,757 | 4,789 |
Series 2005-6 Class EX, 5.5% 11/20/34 | | 1,001 | 988 |
Series 2005-82 Class JV, 5% 6/20/35 | | 1,270 | 1,249 |
Series 2006-2 Class Z, 5.5% 1/20/36 | | 2,875 | 2,878 |
Series 2010-160 Class DY, 4% 12/20/40 | | 13,362 | 12,532 |
Series 2010-168 Class BG, 4% 4/20/40 | | 5,386 | 5,087 |
Series 2010-170 Class B, 4% 12/20/40 | | 2,105 | 1,972 |
Series 2017-139 Class BA, 3% 9/20/47 | | 4,428 | 3,833 |
Series 2018-H12 Class HA, 3.25% 8/20/68 (j) | | 9,523 | 9,058 |
Series 2004-32: | | | |
Class GS, 6.380% - CME Term SOFR 1 Month Index 1.0662% 5/16/34 (b)(h)(i) | | 166 | 8 |
Class SG, 6.380% - CME Term SOFR 1 Month Index 1.0701% 3/20/33 (b)(h)(i) | | 1,905 | 67 |
Series 2004-59 Class SC, 7.080% - CME Term SOFR 1 Month Index 1.7662% 8/16/34 (b)(h)(i) | | 969 | 63 |
Series 2004-73 Class AL, 7.080% - CME Term SOFR 1 Month Index 1.7662% 8/17/34 (b)(h)(i) | | 284 | 20 |
Series 2005-13 Class SA, 6.680% - CME Term SOFR 1 Month Index 1.3701% 2/20/35 (b)(h)(i) | | 1,667 | 116 |
Series 2005-6 Class EY, 5.5% 11/20/33 | | 1,016 | 985 |
Series 2005-82 Class NS, 6.180% - CME Term SOFR 1 Month Index 0.8701% 7/20/34 (b)(h)(i) | | 1,693 | 113 |
Series 2006-13 Class DS, 10.920% x CME Term SOFR 1 Month Index 2.9551% 3/20/36 (b)(c)(i) | | 1,789 | 1,689 |
Series 2007-35 Class SC, 39.510% x CME Term SOFR 1 Month Index 7.5974% 6/16/37 (b)(c)(i) | | 331 | 349 |
Series 2009-13 Class E, 4.5% 3/16/39 | | 1,599 | 1,522 |
Series 2009-42 Class AY, 5% 6/16/37 | | 1,015 | 994 |
Series 2010-H10 Class FA, CME Term SOFR 1 Month Index + 0.440% 5.7767% 5/20/60 (b)(c)(j) | | 2,976 | 2,968 |
Series 2011-52 Class HI, 7% 4/16/41 (h) | | 214 | 30 |
Series 2012-103 Class IL, 3% 8/20/27 (h) | | 4,470 | 134 |
Series 2013-149 Class MA, 2.5% 5/20/40 | | 7,534 | 7,228 |
Series 2013-182 Class IQ, 4.5% 12/16/43 (h) | | 2,599 | 432 |
Series 2014-133 Class IB, 5% 9/20/44 (h) | | 2,483 | 473 |
Series 2014-146 Class EI, 5% 10/20/44 (h) | | 4,764 | 946 |
Series 2014-154 Class IO, 5% 10/20/44 (h) | | 957 | 207 |
Series 2014-158 Class ID, 5% 10/20/44 (h) | | 4,173 | 830 |
Series 2014-178 Class IO, 5% 11/20/44 (h) | | 5,960 | 1,160 |
Series 2014-2 Class BA, 3% 1/20/44 | | 3,194 | 2,823 |
Series 2014-21 Class HA, 3% 2/20/44 | | 1,188 | 1,057 |
Series 2014-25 Class HC, 3% 2/20/44 | | 2,054 | 1,808 |
Series 2014-5 Class A, 3% 1/20/44 | | 1,681 | 1,486 |
Series 2015-117 Class KI, 5% 8/20/45 (h) | | 5,678 | 1,086 |
Series 2015-14 Class IO, 5% 10/20/44 (h) | | 6,467 | 1,241 |
Series 2015-79 Class IC, 5% 5/20/45 (h) | | 3,094 | 594 |
Series 2015-H21: | | | |
Class HZ, 4.2608% 6/20/63 (b)(j) | | 444 | 430 |
Class JZ, 4.4873% 6/20/65 (b)(j) | | 32 | 32 |
Series 2016-146 Class AL, 5.6422% 5/20/40 (b) | | 1,893 | 1,863 |
Series 2016-17 Class A, 3% 2/16/46 | | 12,728 | 11,401 |
Series 2016-171 Class BI, 5% 10/20/44 (h) | | 5,811 | 1,134 |
Series 2017-186 Class HK, 3% 11/16/45 | | 6,064 | 5,376 |
Series 2017-75 Class PT, 5.7226% 4/20/47 (b) | | 7,131 | 6,984 |
Series 2017-H06 Class FA, U.S. TREASURY 1 YEAR INDEX + 0.350% 5.35% 8/20/66 (b)(c)(j) | | 3,640 | 3,623 |
| | | |
TOTAL COLLATERALIZED MORTGAGE OBLIGATIONS (Cost $288,392) | | | 268,005 |
| | | |
Any values shown as $0 in the Schedule of Investments may reflect amounts less than $500.
Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.
Amounts in the dividend income column in the above table include any capital gain distributions from underlying funds.
Amounts in the dividend income column for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities.
Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Securities transactions are accounted for as of trade date. The Board of Trustees (the Board) has designated the Fund's investment adviser as the valuation designee responsible for the fair valuation function and performing fair value determinations as needed. The investment adviser has established a Fair Value Committee (the Committee) to carry out the day-to-day fair valuation responsibilities and has adopted policies and procedures to govern the fair valuation process and the activities of the Committee. In accordance with these fair valuation policies and procedures, which have been approved by the Board, the Fund attempts to obtain prices from one or more third party pricing services or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with the policies and procedures. Factors used in determining fair value vary by investment type and may include market or investment specific events, transaction data, estimated cash flows, and market observations of comparable investments. The frequency that the fair valuation procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee manages the Fund's fair valuation practices and maintains the fair valuation policies and procedures. The Fund's investment adviser reports to the Board information regarding the fair valuation process and related material matters.
The inputs to valuation techniques used to value investments are categorized into a disclosure hierarchy consisting of three levels as shown below:
Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)
Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)
Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing services or from brokers who make markets in such securities. U.S. Government and Government Agency Obligations are valued by pricing services who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. U.S. Government Agency - Mortgage Securities, Collateralized Mortgage Obligations and Commercial Mortgage Securities are valued by pricing services who utilize matrix pricing which considers prepayment speed assumptions, attributes of the collateral, yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing services. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.
Swaps are marked-to-market daily based on valuations from third party pricing services, registered derivatives clearing organizations (clearinghouses) or broker-supplied valuations. These pricing sources may utilize inputs such as interest rate curves, credit spread curves, default possibilities and recovery rates. When independent prices are unavailable or unreliable, swaps may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing services. Swaps are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.
Futures contracts are valued at the settlement price established each day by the board of trade or exchange on which they are traded and are categorized as Level 1 in the hierarchy.
Options traded over-the-counter are valued using service or broker-supplied valuations and are categorized as Level 2 in the hierarchy.
Investments in any open-end mutual funds are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.
Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy.
Risk Exposures and the Use of Derivative Instruments: The Fund's investment objectives allow the Fund to enter into various types of derivative contracts. Derivatives are investments whose value is primarily derived from underlying assets, indices or reference rates and may be transacted on an exchange or over-the-counter (OTC). Derivatives may involve a future commitment to buy or sell a specified asset based on specified terms, to exchange future cash flows at periodic intervals based on a notional principal amount, or for one party to make one or more payments upon the occurrence of specified events in exchange for periodic payments from the other party.
The Fund used derivatives to increase returns, to gain exposure to certain types of assets and/or to manage exposure to certain risks as defined below. The success of any strategy involving derivatives depends on analysis of numerous economic factors, and if the strategies for investment do not work as intended, the Fund may not achieve its objectives.
The Fund's use of derivatives increased or decreased its exposure to the following risk(s):
Interest Rate Risk - Interest rate risk relates to the fluctuations in the value of interest-bearing securities due to changes in the prevailing levels of market interest rates.
The Fund is also exposed to additional risks from investing in derivatives, such as liquidity risk and counterparty credit risk. Liquidity risk is the risk that the Fund will be unable to close out the derivative in the open market in a timely manner. Counterparty credit risk is the risk that the counterparty will not be able to fulfill its obligation to the Fund.
Derivative counterparty credit risk is managed through formal evaluation of the creditworthiness of all potential counterparties. On certain OTC derivatives, the Fund attempts to reduce its exposure to counterparty credit risk by entering into an International Swaps and Derivatives Association, Inc. (ISDA) Master Agreement with each of its counterparties. The ISDA Master Agreement gives the Fund the right to terminate all transactions traded under such agreement upon the deterioration in the credit quality of the counterparty beyond specified levels. The ISDA Master Agreement gives each party the right, upon an event of default by the other party or a termination of the agreement, to close out all transactions traded under such agreement and to net the amounts owed under each transaction to one net payable by one party to the other. To mitigate counterparty credit risk on bi-lateral OTC derivatives, the Fund receives collateral in the form of cash or securities once the Fund's net unrealized appreciation on outstanding derivative contracts under an ISDA Master Agreement exceeds certain applicable thresholds, subject to certain minimum transfer provisions. The collateral received is held in segregated accounts with the Fund's custodian bank in accordance with the collateral agreements entered into between the Fund, the counterparty and the Fund's custodian bank. The Fund could experience delays and costs in gaining access to the collateral even though it is held by the Fund's custodian bank. The Fund's maximum risk of loss from counterparty credit risk related to bi-lateral OTC derivatives is generally the aggregate unrealized appreciation and unpaid counterparty payments in excess of any collateral pledged by the counterparty to the Fund. For OTC written options with upfront premiums received, the Fund is obligated to perform and therefore does not have counterparty risk. For OTC written options with premiums to be received at a future date, the maximum risk of loss from counterparty credit risk is the amount of the premium in excess of any collateral pledged by the counterparty. The Fund may be required to pledge collateral for the benefit of the counterparties on bi-lateral OTC derivatives in an amount not less than each counterparty's unrealized appreciation on outstanding derivative contracts, subject to certain minimum transfer provisions, and any such pledged collateral is identified in the Schedule of Investments. Exchange-traded contracts are not covered by the ISDA Master Agreement; however counterparty credit risk related to these contracts may be mitigated by the protection provided by the exchange on which they trade. Counterparty credit risk related to centrally cleared swaps may be mitigated by the protection provided by the clearinghouse.
Investing in derivatives may involve greater risks than investing in the underlying assets directly and, to varying degrees, may involve risk of loss in excess of any initial investment and collateral received. In addition, there may be the risk that the change in value of the derivative contract does not correspond to the change in value of the underlying instrument.
Futures Contracts: A futures contract is an agreement between two parties to buy or sell a specified underlying instrument for a specified price at a specified future date.
The Fund used futures contracts to manage its exposure to the bond market and fluctuations in interest rates.
Open futures contracts at period end are presented in the Schedule of Investments under the caption "Futures Contracts". The underlying face amount at value reflects each contract's exposure to the underlying instrument or index at period end. Any securities and/or cash deposited to meet initial margin requirements are identified in the Schedule of Investments.
Options: Options give the purchaser the right, but not the obligation, to buy (call) or sell (put) an underlying security or financial instrument at an agreed exercise or strike price between or on certain dates. Options obligate the seller (writer) to buy (put) or sell (call) an underlying instrument at the exercise or strike price or cash settle an underlying derivative instrument if the holder exercises the option on or before the expiration date.
The Fund used OTC options, such as swaptions, which are options where the underlying instrument is a swap, to manage its exposure to fluctuations in interest rates and/or potential credit events.
Open options at period end are presented in the Schedule of Investments under the captions "Purchased Options," "Purchased Swaptions," "Written Options" and "Written Swaptions." Writing puts and buying calls tend to increase exposure to the underlying instrument while buying puts and writing calls tend to decrease exposure to the underlying instrument. For purchased options, risk of loss is limited to the premium paid, and for written options, risk of loss is the change in value in excess of the premium received.
Swaps: A swap is a contract between two parties to exchange future cash flows at periodic intervals based on a notional principal amount.
A centrally cleared swap is a transaction executed between a fund and a dealer counterparty, then cleared by a futures commission merchant (FCM) through a clearinghouse. Once cleared, the clearinghouse serves as a central counterparty, with whom a fund exchanges cash flows for the life of the transaction, similar to transactions in futures contracts.
Interest Rate Swaps: Interest rate swaps are agreements between counterparties to exchange cash flows, one based on a fixed rate, and the other on a floating rate. The Fund entered into interest rate swaps to manage its exposure to interest rate changes. Changes in interest rates can have an effect on both the value of bond holdings as well as the amount of interest income earned. In general, the value of bonds can fall when interest rates rise and can rise when interest rates fall.
For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.
The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.
Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.